Plant-Made Pharmaceuticals Industry Looks Toward Growth in 2005

Share Article

cPMP conference to highlight coming age of PMPs.

As the plant-made pharmaceutical industry looks toward what may be a watershed year in its development, leading representatives of the industry from the U.S., Europe, Canada and Asia are gathering to discuss the opportunities on the horizon and the responsible management of the technology.

The Conference on Plant-Made Pharmaceuticals 2005, which will bring together representatives of some 30 PMP companies and major pharmaceutical corporations from around the world, will include sessions examining plant-made pharmaceuticals from perspectives of business, regulation, science and stewardship.

Major events at the conference, to be held from Jan. 30-Feb. 2 at Montreal’s Fairmont The Queen Elizabeth Hotel, will include the release of results of research conducted on PMPs by the International Alliance of Patient Organizations on behalf of patient-advocacy groups, and a discussion of industry-wide policies and procedures to regulate the production of PMPs.

"The plant-made pharmaceuticals sector has at least doubled in the past two years,” said conference organizer François Arcand. “In 2005 we expect to see major steps forward regarding the involvement of major pharmaceutical companies in PMPs, drug candidates approaching commercialization, increased public financing and regulatory discipline. This conference will be the launching point for much of it.”

Conference hosts include Grand Hosts Bayer CropScience, Dow AgroSciences, Nexgen (Korea) and Syngenta, along with Hosts including Chlorogen, Icon Genetics, Medicago, Meristem and SemBioSys

Plant-made pharmaceuticals are gaining increasing attention for their potential to aid in the production of therapeutic proteins to treat diseases such as cancer, HIV, heart disease, diabetes, Alzheimer’s disease, arthritis and many more.     

The Conference on Plant-Made Pharmaceuticals is organized by the Society for Moleculture, a non-for-profit organization. Its mission is to disseminate information about moleculture and to support the emergence of a manufacturing sector using plant-factories to produce biopharmaceuticals, industrial products and other useful molecules.

For more information or to register for the conference visit


Sarah Fuhrmann

+ 1 314.721.3180

# # #

Share article on social media or email:

View article via:

Pdf Print